ArticleAmerican journal of cancer research2019

Homoharringtonine, an approved anti-leukemia drug, suppresses triple negative breast cancer growth through a rapid reduction of anti-apoptotic protein abundance.

Mohamad Yakhni et al.PubMed ↗Full text ↗

No numbers read from the abstract.